Cell hiding in colorectal cancer: correlation with response to chemotherapy in vitro and in vivo Authors: I Druzhkova, A Potapov, N Ignatova, M Bugrova, I Shchechkin, M Lukina, L Shimolina, E Kolesnikova, M Shirmanova, E Zagaynova Published: 2024 ABSTRACT AbstractResistance to chemotherapy remains the main challenge for cancer treatment. One of the mechanisms of tumor escape from cytotoxic agents could be the formation of cell-in-cell (CIC) structures, in which the outer cell protects the inner cell from unfavorable environment. Such structures have been found in many tumor types, however, their link to chemosensitivity is elusive. Here, we tested whether the CIC structures can promote resistance of colorectal cancer cells to chemotherapy. To identify CIC structures in cell cultures and in tumor xenografts, both transmission electron microscopy and confocal fluorescence microscopy of live and fixed cells as well as tissue slices and histopathology were used. Cytogenetic analysis was performed to detect chromosome instability associated with the drug resistance. It was found that in the five colorectal cancer cell lines intrinsic chemoresistance positively correlated with the ability of cells to spontaneously form CIC structures. Cultured cells treated with oxaliplatin and Irinotecan and tumor xenografts treated with FOLFOX or FOLFIRI regimens displayed an increased number of CICs after the treatment. The release of the inner cell from CIC structure was observed after removal of the drug. The number of CICs in the cell lines and tumors with acquired resistance to oxaliplatin was higher than in the drug-naive counterparts. The development of chemoresistance was also accompanied by the changes in the cell’s ploidy. These preliminary data clearly demonstrate the associations of CIC structures with chemoresistance of colorectal cancer in cultured cells and tumor xenografts and show the prospect of further clinical validation of CICs as a potential prognostic marker for treatment efficiency.Keywords: Cell-in-cell structures, CIC, Chemoresistance, Colorectal cancer, EntosisSubject terms: Cancer, Cell biology, Oncology, Colorectal cancer Introduction Chemotherapy is a “gold standard” for cancer treatment. However, it fails in nearly 90% of cases because tumor cells develop resistance against the anticancer agent, resulting in increased cancer invasion and progression to metastases1. The established mechanisms of chemoresistance include elevated metabolism of xenobiotics, enhanced efflux of drugs, increased DNA repair capacity, and genetic factors (gene mutations, amplifications, and epigenetic alterations)1–4. Participation of the components of the tumor microenvironment, such as extracellular matrix, tumor-infiltrating leukocytes and cancer-associated fibroblasts in the response to treatment and drug resistance development is also widely discussed5–7. One of the possible mechanisms of drug resistance could be the formation of cell-in-cell (CIC) structures that are frequently occurring in cancer and some non-cancerous tissues8,9. CIC, or entotic, structures are formed as a result of the process of entosis, the invasion of a living cell into another cell’s cytoplasm. In general, CIC structures are characterized by the presence of one cell inside another cell of the same or different origin. Depending on the type of cells, CIC structures in cancer can be divided into two major groups: homotypic and heterotypic. A homotypic CIC is formed when, for example, one epithelial cell engulfs another epithelial cell. A heterotypic CIC results from the fusion of an epithelial cell and a cell of different origin, typically an immune cell10. CIC structures were first reported more than a century ago, when Karl J. Eberth found lymphocytes inside intestinal epithelial cells5. Overholtzer et al. described the process of entosis in detail in breast cancer cell line and normal epithelia11,12. Homotypic CIC structures were observed among white blood cells, and the mechanism of the active penetration of one cell into another was proposed13,14. It was noticed that CIC formation is typical both for cells of the immune system and for intestinal cells. Certain physiological processes are accompanied by CICs formation. For instance, during early pregnancy, uterine epithelial cells are internalized by blastocyst trophoblast cells to facilitate embryonic implantation and also engulfment events can occur between pairs of blastomere cells. Different human malignancies, including lung, head and neck, breast, colon, stomach, liver, cervical cancers and melanoma, show the presence of CIC structures11,15–17. Finding of CIC structures during the cytological examination of effusion fluid and urine have been considered as a sign of malignancy18,19. However, the exact role of CIC in tumors is not fully clear. Several studies suggest that CICs mostly contribute to cell death and, therefore, have an anti-tumor effect12,20. Other research shows that CICs have a pro-tumorigenic function. The inner cells can undergo degradation by autophagy within the outer cells, and this provides a survival advantage for the outer cells under stress conditions. Alternatively, multiple membrane layers generated in CIC may act as a mechanical protection for the inner cell against unfavorable environmental factors. In some cases the inner cells undergo cell division within the outer cell or even escape20–22. It was found that in human lung, head and neck, and rectal carcinomas an increased number of homotypic CIC structures correlated with a decrease in patient survival and an increase in disease relapses23–26. On the other hand, a high density of CICs was associated with good prognosis in non-small cell lung cancer, esophageal squamous cell carcinoma and colorectal cancer patients27–29. There are few studies of CICs in the context of chemotherapy. It has been shown that therapy with taxanes15, nintedanib30 as well as the pro-inflammatory signal IL-8 can promote the formation of CIC31. The formation of transient CIC structures has also been demonstrated in response to immunotherapy32. These studies allow us to hypothesize that CIC structures provide a safe environment for the internalized cancer cells and help to evade both chemotoxic drugs and immune surveillance. The purpose of the presented research was to reveal the associations between the ability of cancer cells to form CICs and their sensitivity to chemotherapeutic drugs and to follow generation of CICs upon chemotherapy and acquisition of drug resistance in model systems in vitro and in vivo. The study was performed on colorectal cancer cell cultures and tumor xenografts using confocal fluorescence microscopy, transmission electron microscopy and histopathological investigation to identify CICs. Cytogenetic analysis was used to correlate CICs with genomic instability of cell lines. Cultured cells were treated with chemotherapy drugs oxaliplatin and Irinotecan. Clinically relevant drug combinations FOLFOX and FOLFIRI were applied for chemotherapy of tumors. Materials and methods Cell cultures Human colorectal cancer cell lines HCT116, HT29, SW480, SW837 and CaCo-2 were used in the study. Cell lines were obtained from the Cell Culture Collection of D.I. Ivanovsky Institute of Virology, N.F. Gamaleya National Research Center of Epidemiology and Microbiology (Moscow, Russia). The cells were cultured in DMEM containing 100 µg/mL penicillin, 100 µg/mL streptomycin sulfate and 10% fetal bovine serum at 37 °C in a humidified atmosphere with 5% CO2. Chemoresistant cell lines HCT116-OXAR and HT29-OXAR were established as described in Supplementary information (Supplementary Fig. S1). Chemotherapeutic drugs oxaliplatin (Teva, Israel) and Irinotecan (Teva, Israel) were used. Cells were treated with IC50 doses of the drugs, and CICs were analyzed after 24 h. In the experiment with drug withdrawal, the cells were washed out from the drug and imaged immediately in the time-lapse mode during 6 h. MTT assay To assess cell viability in the presence of the drugs, MTT-assay was performed. Cells were seeded in 96-well plates (5 × 103 cells per well) and incubated for 24 h. oxaliplatin was added in concentrations of 0.1 µM, 0.5 µM, 1 µM, 2 µM, 5 µM, and 10 µM. Irinotecan was added in concentrations of 1 µM, 2.5 µM, 5 µM, 10 µM, 25 µM, 50 µM and 100 µM. In 72 h of incubation the cells were treated with the MTT reagent 3(4,5-dimethyl-2-thiasolyl)-2,5-diphenyl-2H-tetrasolebromide (PanEco, Russia) according to the manufacturer’s protocol and the colorimetric analysis was performed at a wavelength of 570 nm using a multimode microplate reader (Synergy Mx; BioTek Instruments, Winooski, VT, USA). The cell viability was calculated as a percentage of untreated control cells. For each concentration of the drug three independent experiments with 8–10 internal replicates were performed. For each cell line the half-inhibitory concentration IC50 was calculated for both drugs. Transmission electron microscopy Electron microscopy of cell culture samples was performed by the standard protocol. CaCo-2 cells were seeded in 24-well ultra-low attached plates (6 × 105 per well) for 12 h to form CIC structures. Then cells were pelleted by centrifugation for 5 min at 1000 rpm and immediately fixed in 2.5% glutaraldehyde in phosphate buffer (pH 7.4) and 1% solution of osmium tetroxide, then dehydrated in alcohols and acetone and placed in a mixture of 50% embedding medium and 50% of acetone, followed by further embedding in a mixture of Epon and Araldite. 100 nm—thick sections were obtained on a UC7 Leica Microsystems ultramicrotome (Germany) and stained with an alcohol solution of uranyl acetate and lead citrate. The obtained sections were examined using a Morgagni 268D electron microscope (FEI, USA). Tumor xenografts and treatment In vivo experiments were performed on immunodeficient nude mice, females, 3–4 months old, weighing ~ 20 g. The animals were obtained from the specific pathogen free (SPF) vivarium of the Lobachevsky State University (Nizhny Novgorod, Russia). All methods on animals were carried out in accordance with relevant guidelines and regulations approved by the Local Ethical Committee of the Privolzhsky Research Medical University (approval № 09 from 30.06.2023) in accordance with ARRIVE guidelines. Tumors were generated by subcutaneous injection of cell suspension in phosphate-buffered saline (PBS), into the mouse hip. The cell amount per injection was 1*106 cells/100 µl for HCT116 cells and 1.5*106 cells/100 µl for HT29 cells. The treatment was performed using the FOLFOX and FOLFIRI regimens, which are routinely used in clinical practice for colorectal cancer. Treatment started when tumor size was about 5 mm in diameter (7 days of growth). The scheme of the treatment was adopted from ref.33. FOLFOX/FOLFIRI regimens included 10 mg/kg oxaliplatin (Teva, Romania) or 10 mg/kg Irinotecan (Teva, Israel), 8 mg/kg 5-Fluorouracil (Lens, Russia) and 20 mg/kg Leucovorin (Teva, Netherlands). All drugs were injected intraperitoneally on the first day of treatment, then 5-Fluorouracil and Leucovorin—on day 2 to 6. The course was repeated after a 7 day—break. Animals received two treatment courses. Control animals received an equivalent number of saline injections. Tumor size was measured with a caliper three times a week, and volume was calculated as V=a×b×b2, where a is the length and b is the width of a tumor. Tumor growth inhibition (TGI) rate was calculated using the formula: where Vcnt—Mean volume of control tumors, Vtr—Mean volume of treated tumors. Twelve days after the start of the treatment, mice were anesthetized intramuscularly with a mixture of Zoletil (40 mg/kg, 50 μL, Virbac SA, Carros, France) and 2% Rometar (10 mg/kg, 10 μL, Spofa, Czech Republic) and euthanized by cervical dislocation. Tumor nodes were collected and fixed in 10% buffered formalin for 48 h for standard histological and immunohistochemical examinations. Immunostaining of tumor cells and tissues Immunostaining for the epithelial cell adhesion molecule EpCam (CD326) was performed to visualize CICs in treated cell cultures and tumor xenografts. For immunocytochemical analysis cells were seeded in 96-well plates for fluorescence microscopy (Corning, USA) and, after drug treatment, fixed with 4% PFA for 15 min at room temperature, incubated with mouse anti-CD326 primary antibody (10–310,017-01, PrimeBiomed, Russia) overnight at 4C and anti-mouse-IgG secondary antibody conjugated with Alexa 488 (a28175, Abcam) were applied for 1 h. The percentage of CIC structures was calculated from the total cell number in 10 random fields of view. The mean value for each tested group was presented. For tissue staining, the rabbit anti-CD326 primary antibody (HPA026761, Merck, USA) and anti-rabbit-IgG secondary antibody conjugated with Alexa 594 (ab150080, Abcam) were used. Thick (30 µm) slices were obtained from at least three tumors from each experimental group. Slices were deparaffinized, then blocked in 5% horse serum for 1 h and incubated with primary antibodies and then secondary antibodies (24 h at 4 °C for each incubation). DAPI was used for nuclear staining in both cell cultures and tissues. Microscopic investigation was performed using laser scanning microscope LSM880 (Carl Zeiss, Jena, Germany) as described below. The representative confocal images from different depths are presented in Supplementary Fig. S2 A,B. Staining of cells with vital fluorescent dyes To visualize the CICs in live cell cultures the vital fluorescent dyes CFSE (Thermo Fisher Scientific, USA) and Tag-it Violet (BioLegend, USA) were used according to the manufacturer’s protocol. The equal portions of cell suspension stained with each of the dyes were mixed and seeded in ultra-low attachment 24-well plate (Costar, USA), 6 × 105 cells per well in total. After 24 h of incubation 100 µl of cell suspension was cytospun onto a cover glass slide for 5 min at 500 rpm. Confocal microscopy images were obtained using LSM880 (Carl Zeiss, Jena, Germany) with a 40x/1.3 oil immersion objective. Time-lapse microscopy was performed for at least 8 h every 15 min to obtain video. To verify that one cell located insight another z-stack images were captured. The excitation and emission wavelengths for different dyes are presented in Table 1. The images were processed using ZEN Software (Carl Zeiss, Germany) or ImageJ Software. The percentage of CIC structures was calculated from the total cell number in 10 random fields of view. The mean value for each tested group was presented. Table 1The excitation and emission wavelengths used on LSM880.Fluorescent dyeλex, nmλem, nmCFSE Alexa 488488500–530Alexa 594543585–733Tag-it Violet DAPI405410–579 The excitation and emission wavelengths used on LSM880. To observe CICs after withdrawal of the drug, one portion of HT29 cells was stained with CFSE dye and then mixed with an equal portion of unstained cells. Then cells were seeded on a glass-bottom dish and incubated for 24 h. Afterwards, Irinotecan (IC50) was added, and cells were incubated for an additional 24 h. Then the culture medium was changed to one without the drug, and the nuclear dye Hoechst was added. Immediately cells were visualized using a confocal microscope in a time-lapse mode. Histopathological investigation of CICs To evaluate CICs in tumor xenografts obtained from the HCT116 and HT29 cell lines, 4 μm-thick histological sections were prepared and subjected to a standard hematoxylin–eosin (H&E) staining procedure. Tissue slices were examined using Leica microscope DM 2500 (Germany). The search of CIC structures was performed by a qualified pathologist using a N Plan 100x/1,25 oil immersion objective. During the search, when suspicious structures met, the focus was adjusted for more reliable identification of CICs, since the internalized cell and the host cell do not always lie in the same plane parallel to the plane of the section. CICs were calculated in 15 random fields of view in the tumor center and in the tumor periphery, excluding necrotic areas. Structures that had at least four of the following six features were considered as CICs: nucleus of internalized cell, cytoplasm of internalized cell, nucleus of engulfing cell, cytoplasm of engulfing cell, ‘moon-shape’ host nucleus, intervening vacuolar space, as described previously by MacKay17. Internalized cells with the signs of apoptosis (cell shrinkage, karyopyknosis, hypereosinophilic cytoplasm) or internalized apoptotic bodies were not taken into account (Supplementary Fig. S2 C). Chromosome spread analysis For chromosome spread analysis cells were treated with 100 ng/ml colchicine (PanEco, Russia) for 20 h, then harvested by mitotic shake off and hypotonically swollen in 0.075 M KCl for 35 min at 37 °C. Cells were fixed in ethanol/acetic acid (3:1), dried at 65C overnight and then stained with 5% Giemsa (PanEco, Russia) for 1 min. After rinsing in water, the preparations were observed under light microscope with oil immersion objective N-Achroplan 100x/1.25 (Carl Zeiss, Germany). At least 100 metaphase spreads were counted for control and for oxaliplatin-resistant cell lines. General scheme of experiments with a short list of materials and methods is presented in Fig. 1. Workflow of the experiments on cultured cells in vitro and tumor xenografts in vivo. Statistical analysis All quantitative data obtained during the in vitro and in vivo experiments were analyzed for normality using the Shapiro–Wilk test. The p-value was > 0.15 for all groups, indicating normal data distribution. Thus, the values below ​​are presented as mean ± standard deviation (SD). A one-tailed Student’s t-test was used to test statistical significance between two groups (number of CIC structures in the center and the periphery of the tumors). To test statistical significance for more than two groups (percentage of CICs in different cell cultures during drug exposure, number of CIC structures in tumor xenografts during chemotherapy, tumor growth), a one-way analysis of variance (ANOVA) with Bonferroni correction for multiple hypothesis testing was used. Correlation analysis of normally distributed and unrelated groups was performed using the Pearson correlation coefficient (correlation between the number of CICs and IC50 values). Differences were considered statistically significant if the p-value was < 0.05. Calculations were performed using Statistica 10.0 software. Graphical presentation of data was performed using GraphPad Prism 10 software. The quantitative data obtained during the chromosome distribution analysis had a non-normal distribution (Shapiro–Wilk test p-value was < 0.05), so the Mann–Whitney test was used to test statistical significance. Calculations were performed using Microsoft Visual Studio version 1.90.2, python version 3.10.12. Results CICs in different colorectal cancer cell lines and their correlation with chemosensitivity Using vital fluorescent dyes and confocal microscopy the formation of CICs was observed in all cancer cell lines used. The ability to spontaneous formation of CIC structures was assessed in suspension cultures using vital dyes CFSE and Tag-it Violet. The percentage of CICs was the highest in the CaCo-2 cell line, 18.0 ± 2.9%, that has an unusual morphology in comparison with other cell lines. CaCo-2 cells formed CICs in both suspension and adherent cultures (Fig. 2A). The lowest amount of CICs was found in HCT116 cell line, 1.0 ± 0.4%. In other cell lines the amount of CICs decreased in the order SW837 (11.85%) > HT29 (3.6%) > SW480 (1.98%). CIC structures in five colorectal cancer cell lines and their correlation with chemosensitivity. A–Representative confocal fluorescence images of HCT116, CaCo-2, HT29, SW480, SW837 cells in suspension cultures. Green color—CFSE dye, blue color—Tag-it Violet dye. White arrows indicate the CIC structures. The main morphological sign of CICs in fluorescence microscopy images is a cytoplasmic rim of one color around a spherical cell of a different color. Bar = 50 µm. B–Representative confocal z-stack of fluorescence images of CaCo-2 cells showing the CIC structure. C–Representative transmission electron microscopy image of CaCo-2 cells showing the CIC structure. Bar = 2 µm. D–IC50 values for the tested cell lines, E–CICs percentage in the tested cell lines (suspension culture). P-values for multiple comparison of all cell lines are presented in Supplementary Table S1. F–Correlation between IC50 values and CICs percentage in five cancer cell lines. The presence of CIC structures, which are displayed as one cell inside another cell, was confirmed by confocal microscopy in Z-scanning mode and also by transmission electron microscopy (Fig. 2 B, C). The supplementary video clearly demonstrates the process of internalization of the neighbor cell into the host cell (Supplementary video S1, video S2). The assessment of chemosensitivity of cell lines to Irinotecan and oxaliplatin revealed that CaCo-2 is the most resistant one to both drugs (Fig. 2 D,E). The IC50 values were 44.4 and 32.8 nM, for Irinotecan and oxaliplatin correspondingly. HCT116 was the more sensitive to oxaliplatin, IC50 1.1 µM, and SW480 was the more sensitive to Irinotecan, IC50 1.7 nM. A good positive correlation was found between the number of CICs in the cell cultures and the IC50 values. The Pearson correlation coefficient (r) was 0.78 for Irinotecan and 0.84 for oxaliplatin (Fig. 2 F), which indicates a strong association of CICs with chemosensitivity of cell lines. CICs formation during drug exposure in vitro To test if cell internalization contributes to cell survival during chemotherapy, CaCo-2, HCT116 and HT29 cells were treated with oxaliplatin or Irinotecan in IC50 doses for 24 h (Fig. 3). The use of vital fluorescent dyes for observation of CICs was limited in these experiments due to the enhanced efflux of Tag-it Violet dye from the cells under drug exposure. So, cells were fixed and stained using antibodies to EpCam for visualization of cell membranes and DAPI for visualization of cell nuclei. It was found that short-term exposure to the drugs for 24 h increases the number of CICs in all cell lines. Treatment of CaCo-2 cells with any of the drugs resulted in ~ twofold increase of the number of CICs, from ~ 11 to 20%. After treatment of HT29 cells with Irinotecan the number of CICs was ~ sixfold higher than in control (3.8 ± 2.2 vs. 26.1 ± 1.9%, p < 0.0001), and after treatment with oxaliplatin—~ fourfold higher (3.8 ± 2.2 vs. 15,5 ± 3.9%, p = 0.0484). In the case of HCT116 cells, changes in the number of CICs were insignificant due to intrinsically low ability of this cell line to generate CIC structures. CICs formation in cancer cell cultures during drug exposure. A–Representative fluorescence microscopy images of Caco-2 (A), HT29 (B) and HCT116 (C) cell lines exposed to oxaliplatin or Irinotecan and untreated controls. Dotted circles and arrows indicate CIC structures. Bar = 50 µm for all images. D–Percentage of CICs in colorectal cancer cell lines after 24 h incubation with the drugs and in the untreated control. Mean ± SD, n = 10 fields of view. P-values are indicated on the diagram. Interestingly, further withdrawal of the drug resulted in release of the inner cells from the host cells, confirming that the formation of CICs favors survival of cells during chemotherapy (Supplementary video S3). CICs formation during drug exposure in vivo To assess CICs formation upon treatment in vivo we performed the experiments on tumor xenografts generated from HCT116 and HT29 cells with different chemosensitivity. The CaCo-2 cell line was excluded from the study at this stage since it has low ability to form a tumor in nude mice and the resulting tumors grow very slowly34, which make it difficult to compare the results with other tumor types. A detailed histopathological analysis revealed the presence of CIC structures in untreated control tumor xenografts of both types. The observed CICs had different morphology. Specifically, there were CICs with and without an entotic vacuole around the inner cell and with features of the atypical mitosis in the inner cell (Fig. 4 A,B). The number of CICs was generally comparable in HCT116 and HT29 tumors and varied from 7 to 25 in 15 microscopic fields of view at × 100 magnification. Separate counting of CICs in the tumor center and periphery demonstrated statistically significant differences in both tumor types with the greater amount of CICs in the periphery (Fig. 4C). CIC formation in colorectal tumor xenografts during chemotherapy in vivo. Representative microscopic images of HT29 (A) and HCT116 (B) tumors. Histopathological (H&E) images and fluorescence microscopy images (DAPI, EpCam). Colored squares show corresponding enlarged areas with CICs of different morphology: entotic vacuole around the inner cell (yellow and blue squares), absence of entotic vacuole (green and blue squares), atypical mitosis in the inner cell (blue and black squares). Black and white dotted circles indicate non-enlarged CIC structures in the images. Bar = 50 µm, applicable to all images. C–The number of CIC structures in the center and periphery of HT29 and HCT116 tumors (untreated control and after FOLFOX or FOLFIRI treatment). Mean ± SD, n = 5 tumors, total of 15 fields of view. P values are indicated on the diagrams. D—HT29 and HCT116 tumor growth during FOLFOX and FOLFIRI treatment. *—p < 0.05 with the control group. FOLFOX and FOLFIRI regimens demonstrated moderate therapeutic effect in both tumor types (Fig. 4D). Maximum tumor growth inhibition (TGI) rate was achieved by 12 days of treatment (FOLFOX: 57.5% for HCT116 and 45.3% for HT29, FOLFIRI: 65.2% for HCT116 and 35.3% HT29. The number of CIC structures in the periphery of HT29 xenografts was higher after the treatment with any regimen compared with untreated tumors. In HCT116 tumors, significant increase was observed only in the periphery with the FOLFIRI regimen (Fig. 4 A,B). The observed differences between the center and periphery of tumors in the number of CICs and their more pronounced increase in this area after chemotherapy are probably associated with the more active functional state of the cells. Unlike the central area, the periphery of the tumor contains less necrotic zones, less apoptotic cells and cells with dystrophic changes (e.g. in the form of swelling), and in general is more viable. It should be noted that all CICs found in the tumor tissue were homotypic and included two or more epithelial cells. Therefore, the more resistant HT29 cells showed poorer response to both therapeutic regimes in vivo, which was accompanied by the more active formation of CIC structures in the tumor tissue. CICs in cell cultures and tumors with acquired chemoresistance Next, we explored whether formation of CICs accompanies the development of drug-resistant cell phenotype. For this, cell lines with acquired resistance to oxaliplatin were used, HCT116-OXAR and HT29-OXAR. The chemoresistant cell lines were obtained as described in Ref35, the detailed information is presented in Supplementary (Supplementary Fig. S1). It was found that with acquisition of resistance to oxaliplatin the percentage of CICs in HCT116 cell culture increased ~ 8.3-fold and accounted for 6.4 ± 1.0% of the total number of cells. In HT29 cell culture, the number of CICs increased ~ 2.7-fold to 10.2 ± 1.0% (Fig. 5). CIC structures in chemoresistant cells and tumors. A–Representative fluorescence microscopy images of parental HCT116 cell line and its oxaliplatin-resistant analogue HCT116-OXAR. B–Representative fluorescence microscopy images of parental HT29 cell line and its oxaliplatin-resistant analogue HT29-OXAR. C–Representative histopathological (H&E) and fluorescence microscopy images of HCT116 tumors and oxaliplatin-resistant analogue. Dotted circles and arrows indicate CIC structures in the images. Bar = 50 µm, applicable to all images. D–Quantification of CICs in parental (control) and oxaliplatin-resistant (OXAR) HCT116 and HT29 cell lines. Mean ± SD, n = 10 fields of view. E–The number of CIC structures in the center and periphery of parental (control) and oxaliplatin-resistant (OXAR) HCT116 tumor xenografts. Mean ± SD, n = 5 tumors, 15 fields of view in each. P-values are indicated on the diagrams. The number of CICs in drug-resistant tumor xenografts generated from HCT116-OXAR cell line was also greater than in the drug-naive counterpart. In the tumor center the number of CICs was on average 23.5 in 15 fields of view compared with 8.75 in control (p = 0.0286). In the periphery, it was 51.25 compared with 19.75 in control (p = 0.0286) (Fig. 5 C, E). Chromosome spread analysis It is assumed that entosis may promote tumor progression by inducing changes in a cell ploidy25,36,37. To verify this, the cytogenetic analysis of drug-naive and oxaliplatin-resistant cell lines was performed. The majority of cells (68%) initially had 41–50 chromosomes per cell in the case of HCT116 cells. 16% of cells were polyploid with the number of chromosomes from 51 to 94 and in 16% of cells the residual number of chromosomes was less than 40. Upon acquisition of drug resistance the population of cells with 41–50 chromosomes increased to 79%, the percentage of polyploid cells decreased to 3% and the amount of cells with residual number of chromosomes increased to 22%. Statistical analysis with alternative hypotheses showed that a decrease of the average number of chromosomes per cell in HCT116-OXAR cell line was statistically significant (p = 0.009) (Fig. 6 A,C). Previous observations suggest that such changes indirectly indicate that some cells in the population could be descendants of the polyploid ones, which had escaped elimination and underwent improper divisions38. Chromosome spread analysis in parental cell cultures and their oxaliplatin-resistant analogues. Frequency distribution of chromosomes in HCT116 (A) and HT29 (B) cell lines. Representative images of metaphase spreads with different chromosome numbers in HCT116 (C) and HT29 (D) cells. The number of chromosomes is indicated on the images. The majority of cells (80%) was nearly triploid with chromosomes number 60–80 in the HT29 cell line (Fig. 6 B, D). 15% of cells had less than 60 chromosomes and 5% of cells had more than 80 chromosomes per cell. In the oxaliplatin-resistant cell line HT29-OXAR, the middle population was 76%, cells with residual chromosomes number was 11% and the percentage of cells with a large number of chromosomes (up to 140) became 13%. The increase of the average chromosome number per cell in the drug resistance cell line was statistically significant (p < 0.0001). Therefore, our study clearly demonstrated that prolonged drug exposure of HT29 cells led to the polyploidy. Discussion Chemotherapy remains the first-line treatment for many cancers in advanced stages. However, the reasons for treatment failure and the mechanisms of drug resistance are still not completely clear39. Morphological “cell-in-cell” structures have received increased attention as potential markers of drug resistance of tumors11,40,41 because they can be identified in the routine histopathological slices and may add valuable information at the stage of tumor diagnosis. Colorectal cancer is the third most common cancer worldwide42. There are many studies related to CICs structures in colorectal cancer and their significance for disease progression, however the results of these studies are quite controversial. For example, study by Schwegler et al., demonstrated that either low numbers or the absence of CIC structures had a beneficial prognostic value in rectal cancer, while high number of CICs had a positive impact on local failure-free survival for anal cancer43. Also in the other study the overall survival of patients depending on the frequency of entotic events did not show statistically significant results, but indicated a positive trend29. Our study was performed using five human colorectal cell lines, which are well characterized and frequently used for investigation of drug toxicity. Here, we clearly demonstrate the positive correlation between chemoresistance and the amount of CIC structures in colorectal cancer cell lines in vitro and mouse tumors in vivo. To the best of our knowledge, this study is the first that shows the association of CICs structures in colorectal cancer with sensitivity to chemotherapy. It was found that the formation of CIC structures had a negative correlation with the sensitivity to chemotherapeutic drugs oxaliplatin and Irinotecan in five colorectal cell lines. However, there was no correlation between chemosensitivity and mutation status of the main genes suspected of forming chemoresistance such as TP53, blocking apoptosis, PIK3CA, activating LGR5 + CRC stem cells survival and proliferation, and BRAF, activating MAPK pathway (Table S2) 44–47. Such aspects of cancer cell biology as expression of integrins, plasticity of actin cytoskeleton and cell membrane composition may underlie the different ability of cancer cells to spontaneous CIC formation48,49. Although HCT116 cells showed lower ability to generate CIC structures in vitro compared to HT29, it was noted that the number of CICs in the tumors was generally comparable. The discrepancy between the in vitro and in vivo findings can be explained by the influence of the microenvironment on the ability of cells to form CICs. Particularly, it is known that nutrition starvation can promote CIC structures formation21. It is possible that the HCT116 cell growth in the condition of nutrient deficiency in vivo could stimulate CIC structures formation, unlike in vitro conditions, where nutrients are freely available in the culture medium. Next, it was shown that chemotherapy of cultured cells and tumors stimulates the formation of CICs. This result is consistent with the idea that hiding of the inner cell by the outer cell protects the former in stressful conditions. One of the first assumptions about the formation of such a safe space for the inner cell was made in 1992 by Wu and Raine in the study of association of oligodendrocytes and hypertrophic astrocytes in multiple sclerosis lesions50. The ability of certain drugs, including taxans and nintedanib as well the pro-inflammatory signal IL-8, to promote CIC formation favors this idea15,26,30,31. In the study by Liu et al. entosis was observed in prostate cancer in vitro and in vivo after nintedanib treatment30. Nintedanib is a small molecule tyrosine kinase inhibitor, commonly used as an antifibrotic drug and also for treatment of non-small cell lung cancer51. In the study by Durgan et al. it was shown that taxane treatment might influence cell cannibalism by modulating mitotic entosis in human bronchial epithelial cells. Formation of transient homotypic CIC structures was shown by Gutwillig et al. in tumor cells evading immunotherapy, where transient CICs were resistant to killing by T-cells32. CIC structures formation in colorectal cancer in response to clinically-relevant cytotoxic drugs has not been demonstrated before. Even if the inner cell is digested by the host cell, there may be an overall increase in tumor cells’ survival due to obtaining a survival advantage by the host cell, as shown in several studies21,22,52. An elevated number of CIC structures was found during development of chemoresistance in HCT116 and HT29 cell lines. Acquisition of drug resistance is promoted by different mechanisms, including genomic instability, activation of drug efflux pumps, mitochondrial alterations, DNA repair, autophagy, epithelial-mesenchymal transition, to name a few53–55. It is likely that some of these adaptive mechanisms could favor CICs formation. For instance, Rho/ROCK signaling pathway is known to be involved in entotic activity56 and also in regulation of chemoresistance in hepatocellular carcinoma57. A member of the Rho GTPase protein family phosphoinositide 3-kinase (PI3K)/cell division cycle 42 (CDC42) plays a key role in local actin organization and is involved in the cell entosis process at list in prostate cancer and bronchial epithelial cells15,30. CDC42 is a master regulator of epithelial cells morphogenesis together with PTEN, the deficiency of which was associated with formation of abnormal 3-D cell structures, particularly in CaCo-2 cells58,59. In the study by Hayashi the genetic and clinical correlation of entosis in pancreatic ductal adenocarcinoma was analyzed. Entotic-CIC activity positively correlated with TP53 mutations, KRas and c-Myc amplification, while deep deletions for CDKN2A, TP53, or SMAD4 did not demonstrate such correlation60. Conferring winner status of KRas and c-Myc mutated cells was shown in other cancer types as well29,49. Development of mechanical differentials between neighboring cells resulted in the formation of CICs, was shown to be regulated through the AMPK and JNK/p38 stress signaling21,61,62. However, for the tested five lines we did not found any correlation between CICs formation activity and mutation state in some critical cancer genes, listed in table S2. Some studies have shown that entosis may promote tumor progression by inducing changes in cell ploidy (i.e. formation of polyploid and aneuploid cells), thus increasing their malignant potential2,25,36,37. In our study the increase of the number of CICs in two cell lines (HT29 and HCT116) due to development of chemoresistance to oxaliplatin was observed. At the same time, chromosome spread analysis demonstrated changes in the number of chromosomes. The increase of chromosome number per cell associated with high genome instability was registered in the oxaliplatin-resistant HT29 cell line relative to the parental line. On the contrary, in the oxaliplatin-resistant HCT116 cell line, there was an increase of cells with reduced chromosome number. However, the observed changes for both cell lines are likely to follow the same scenario. Most likely polyploidy cells were formed as a result of the oxaliplatin exposure and probably CIC structures formation and then inappropriate divisions lead to abnormalities in the number of chromosomes. The observed differences between the two cell lines can be explained by the different status of the TP53 gene. HCT116 cell line has a wild-type p53, while HT29 has a mutant p53-R273H and continues to undergo abnormal mitotic events, leading to multinucleated and tripolar mitotic events. In the study by Sliwinska et al. the increased genomic instability and changes in the number of chromosomes similar to our observations were found in HCT116 cell line during development of cellular senescence upon Doxorubicin treatment38. Tonnessen-Murray et al. have observed that Doxorubicin-induced senescence was accompanied by the enhanced formation of CICs in MCF7 cell line52. All these data suggest that CIC structures formation might be the cause of cell ploidy changes and genome instability. With regard to the differences in chromosome changes upon acquisition of drug resistance by HT29 and HCT116 cells, they are most likely related to the different state of the TP53 gene in these cell lines, which regulates the cell cycle24,62. Our results suggest that the formation of homotypic CIC structures by cancer cells is an acute reaction to the toxic effect of chemotherapeutic drugs in vitro and in vivo, which correlates with resistance to the drug. The more resistant the cells are, the more CICs they generate both spontaneously and upon drug exposure. A limitation of our study is that the link between CICs structures and chemosensitivity was demonstrated only in experimental conditions in cultured cell lines and mouse tumor models. Further validation of these results on patient-derived samples is needed to conclude about a clinical relevance of CICs as a prognostic marker of drug sensitivity. Development of a protocol for analysis of CIC structures in patients’ samples and analysis of CICs in patients’ tumors under different therapeutic regimes will be the subject of future research. Another limitation of the study is that evaluation and counting of CICs in histological slices is performed “manually”. The algorithms for automatic recognition of CICs on the basis of machine learning approaches should be developed to improve the throughput of the data analysis and exclude human factors. Conclusions In summary, our study provides an insight into the role of CICs in tumor tissue. CICs were identified in a panel of colorectal cancer cell lines and tumor tissues using electron microscopy and fluorescence confocal microscopy. The ability of cells to generate CICs negatively correlated with their sensitivity to the cytotoxic drugs oxaliplatin and Irinotecan. The number of CICs increased both upon short-term drug exposures and acquisition of drug resistance upon long-term treatment, which suggest that CICs have a protective function for the cells that are internalized by other cells and can, therefore, survive the treatment and release. Although our study is rather preliminary and does not include patients’ material and verification of molecular mechanisms of CICs formation, the data obtained show the prospects for further investigations of prognostic value of CICs in tumor tissue samples. Supplementary Information Supplementary Information 1. Supplementary Video 1. Supplementary Video 2. Supplementary Video 3. Acknowledgements Authors thanks Dmitry Kozlov (PRMU) for valuable consultation during chromosome spread analysis, Maria Karabut and Alexandra Bogomolova (PRMU) for preparation of histological slices, Dr. Vladislav Shcheslavskiy (PRMU) for valuable consultations. Author contributions ID, AP, conceptualized the study. ID, NI, MB, ML, EK and LS (Liubov Shimolina) carried out experiments. ID, AP and IS analyzed the data. ID, AP, and MS, writing the original paper. ID and MS writing the final approval of the submitted and published version. EZ, supervised the work. Funding Analysis of the cell-in-cell structures was supported by the Ministry of Healthcare of the Russian Federation (project No. 056–03-2024–046 “Cell-in-cell morphological structures as a prognostic criterion for the progression of cancer”). In vivo treatment with FOLFOX and FOLFIRI regimen and verification of therapeutic effects was supported by the Russian Science Foundation grant № 23–15-00294. Data availability The datasets used and/or analysed during the current study available from the corresponding author on reasonable request. Declarations Competing interests The authors declare no competing interests. Ethics approval This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Privolzhsky Research Medical University (Approval No. 09 from 30.06.2023). Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Supplementary Information The online version contains supplementary material available at 10.1038/s41598-024-79948-1. References Associated Data Supplementary Materials Supplementary Information 1. Supplementary Video 1. Supplementary Video 2. Supplementary Video 3. Data Availability Statement The datasets used and/or analysed during the current study available from the corresponding author on reasonable request.